Geode Capital Management’s Decibel Therapeutics, Inc. Common Stock DBTX Stock Holding History

Geode Capital Management’s Portfolio DBTX Stock Details DBTX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q3	–	Sell	-115,567	Closed	-$445K	–	4816
2023 Q2	$445K	Hold	115,567	–	–	﹤0.01%	3691
2023 Q1	$349K	Hold	115,567	–	–	﹤0.01%	3791
2022 Q4	$236K	Buy	115,567 +4,170	+4%	+$12.7K	﹤0.01%	4006
2022 Q3	$385K	Buy	111,397 +40,594	+57%	+$185K	﹤0.01%	3868
2022 Q2	$298K	Buy	70,803 +1,520	+2%	+$3.59K	﹤0.01%	4029
2022 Q1	$210K	Hold	69,283	–	–	﹤0.01%	4357
2021 Q4	$322K	Sell	69,283 -273	-0.4%	-$1.88K	﹤0.01%	4266
2021 Q3	$536K	Sell	69,556 -2,292	-3%	-$17.5K	﹤0.01%	4000
2021 Q2	$617K	Sell	71,848 -38,096	-35%	-$336K	﹤0.01%	3840
2021 Q1	$1.25M	Buy	+109,944	New	+$1.73M	﹤0.01%	3463

Other funds holding DBTX

ACA

Atlas Capital Advisors Jackson, Wyoming $914M AUM

Geode Capital Management's DBTX Position: Q3 2023 in Review

Geode Capital Management sold out of Decibel Therapeutics, Inc. Common Stock (DBTX) in Q3 2023, closing a stake of 115,567 shares — an estimated $445K sold.

Geode Capital Management first reported a position in DBTX in Q1 2021 and held it in 10 quarters. The position peaked at $1.25M in Q1 2021. 1 fund tracked by Wall St. Rank holds DBTX as of Q3 2023.

Geode Capital Management reported no remaining Decibel Therapeutics, Inc. Common Stock position as of Q3 2023 after selling out during the quarter.
Geode Capital Management sold 115,567 Decibel Therapeutics, Inc. Common Stock shares in Q3 2023, an estimated $445K.
Geode Capital Management first reported a position in Decibel Therapeutics, Inc. Common Stock in Q1 2021 and held it in 10 quarters.
Geode Capital Management's Decibel Therapeutics, Inc. Common Stock position peaked at $1.25M in Q1 2021.
1 fund tracked by Wall St. Rank held Decibel Therapeutics, Inc. Common Stock as of Q3 2023.

Based on Geode Capital Management's 13F filing for Q3 2023, filed 13 Nov 2023.